Abstract
Randomised trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer: preliminary results of the SITAM-01
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
